{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:32:09Z","timestamp":1791145929022,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"20","license":[{"start":{"date-parts":[[2011,10,3]],"date-time":"2011-10-03T00:00:00Z","timestamp":1317600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,10,3]],"date-time":"2011-10-03T00:00:00Z","timestamp":1317600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2012,5,17]]},"DOI":"10.1038\/onc.2011.429","type":"journal-article","created":{"date-parts":[[2011,10,3]],"date-time":"2011-10-03T10:40:05Z","timestamp":1317638405000},"page":"2521-2534","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":192,"title":["Tissue transglutaminase links TGF-\u03b2, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer"],"prefix":"10.1038","volume":"31","author":[{"given":"L","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Schilder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Guise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K S","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Matei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,3]]},"reference":[{"key":"BFonc2011429_CR1","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1006\/cyto.1999.0632","volume":"12","author":"B Abendstein","year":"2000","unstructured":"Abendstein B, Stadlmann S, Knabbe C, Buck M, Muller-Holzner E, Zeimet AG et al. (2000). Regulation of transforming growth factor-beta secretion by human peritoneal mesothelial and ovarian carcinoma cells. Cytokine 12: 1115\u20131119.","journal-title":"Cytokine"},{"key":"BFonc2011429_CR2","first-page":"S44","volume":"11","author":"RJ Akhurst","year":"2001","unstructured":"Akhurst RJ, Derynck R . (2001). TGF-beta signaling in cancer--a double-edged sword. Trends Cell Biol 11: S44\u2013S51.","journal-title":"Trends Cell Biol"},{"key":"BFonc2011429_CR3","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1182\/blood.V98.5.1567","volume":"98","author":"SS Akimov","year":"2001","unstructured":"Akimov SS, Belkin AM . (2001). Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. Blood 98: 1567\u20131576.","journal-title":"Blood"},{"key":"BFonc2011429_CR4","doi-asserted-by":"publisher","first-page":"7274","DOI":"10.1038\/sj.onc.1207947","volume":"23","author":"M Al-Hajj","year":"2004","unstructured":"Al-Hajj M, Clarke MF . (2004). Self-renewal and solid tumor stem cells. Oncogene 23: 7274\u20137282.","journal-title":"Oncogene"},{"key":"BFonc2011429_CR5","first-page":"1413","volume":"63","author":"RL Baldwin","year":"2003","unstructured":"Baldwin RL, Tran H, Karlan BY . (2003). Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta\/Smad signaling. Cancer Res 63: 1413\u20131419.","journal-title":"Cancer Res"},{"key":"BFonc2011429_CR6","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1016\/S0959-8049(97)00304-3","volume":"33","author":"JM Bartlett","year":"1997","unstructured":"Bartlett JM, Langdon SP, Scott WN, Love SB, Miller EP, Katsaros D et al. (1997). Transforming growth factor-beta isoform expression in human ovarian tumours. Eur J Cancer 33: 2397\u20132403.","journal-title":"Eur J Cancer"},{"key":"BFonc2011429_CR7","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<658::AID-CNCR16>3.0.CO;2-M","volume":"85","author":"RE Bristow","year":"1999","unstructured":"Bristow RE, Baldwin RL, Yamada SD, Korc M, Karlan BY . (1999). Altered expression of transforming growth factor-beta ligands and receptors in primary and recurrent ovarian carcinoma. Cancer 85: 658\u2013668.","journal-title":"Cancer"},{"key":"BFonc2011429_CR8","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1093\/carcin\/bgn158","volume":"29","author":"L Cao","year":"2008","unstructured":"Cao L, Petrusca DN, Satpathy M, Nakshatri H, Petrache I, Matei D . (2008). Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling. Carcinogenesis 29: 1893\u20131900.","journal-title":"Carcinogenesis"},{"key":"BFonc2011429_CR9","first-page":"49","volume":"16","author":"MR Cardillo","year":"1997","unstructured":"Cardillo MR, Yap E, Castagna G . (1997). Molecular genetic analysis of TGF-beta1 in ovarian neoplasia. J Exp Clin Cancer Res 16: 49\u201356.","journal-title":"J Exp Clin Cancer Res"},{"key":"BFonc2011429_CR10","first-page":"4679","volume":"61","author":"T Chen","year":"2001","unstructured":"Chen T, Triplett J, Dehner B, Hurst B, Colligan B, Pemberton J et al. (2001). Transforming growth factor-beta receptor type I gene is frequently mutated in ovarian carcinomas. Cancer Res 61: 4679\u20134682.","journal-title":"Cancer Res"},{"key":"BFonc2011429_CR11","doi-asserted-by":"publisher","first-page":"27825","DOI":"10.1074\/jbc.M111.226340","volume":"286","author":"CY Chou","year":"2011","unstructured":"Chou CY, Streets AJ, Watson PF, Huang L, Verderio EA, Johnson TS . (2011). A crucial sequence for transglutaminase type 2 extracellular trafficking in renal tubular epithelial cells lies in its N-terminal {beta}-sandwich domain. J Biol Chem 286: 27825\u201327835.","journal-title":"J Biol Chem"},{"key":"BFonc2011429_CR12","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S1097-2765(01)00260-X","volume":"7","author":"J Comijn","year":"2001","unstructured":"Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E et al. (2001). The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 7: 1267\u20131278.","journal-title":"Mol Cell"},{"key":"BFonc2011429_CR13","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1073\/pnas.88.2.580","volume":"88","author":"PA Dennis","year":"1991","unstructured":"Dennis PA, Rifkin DB . (1991). Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate\/insulin-like growth factor type II receptor. Proc Natl Acad Sci USA 88: 580\u2013584.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2011429_CR14","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nature02006","volume":"425","author":"R Derynck","year":"2003","unstructured":"Derynck R, Zhang YE . (2003). Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425: 577\u2013584.","journal-title":"Nature"},{"key":"BFonc2011429_CR15","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1101\/gad.1061803","volume":"17","author":"G Dontu","year":"2003","unstructured":"Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ et al. (2003). In vitro propagation and transcriptional profiling of human mammary stem\/progenitor cells. Genes Dev 17: 1253\u20131270.","journal-title":"Genes Dev"},{"key":"BFonc2011429_CR16","doi-asserted-by":"publisher","first-page":"44377","DOI":"10.1074\/jbc.M307202200","volume":"278","author":"SC Dowdy","year":"2003","unstructured":"Dowdy SC, Mariani A, Janknecht R . (2003). HER2\/Neu- and TAK1-mediated up-regulation of the transforming growth factor beta inhibitor Smad7 via the ETS protein ER81. J Biol Chem 278: 44377\u201344384.","journal-title":"J Biol Chem"},{"key":"BFonc2011429_CR17","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1074\/jbc.M204623200","volume":"278","author":"N Dumont","year":"2003","unstructured":"Dumont N, Bakin AV, Arteaga CL . (2003). Autocrine transforming growth factor-beta signaling mediates Smad-independent motility in human cancer cells. J Biol Chem 278: 3275\u20133285.","journal-title":"J Biol Chem"},{"key":"BFonc2011429_CR18","first-page":"5358","volume":"62","author":"L Gillan","year":"2002","unstructured":"Gillan L, Matei D, Fishman DA, Gerbin CS, Karlan BY, Chang DD . (2002). Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Res 62: 5358\u20135364.","journal-title":"Cancer Res"},{"key":"BFonc2011429_CR19","doi-asserted-by":"publisher","first-page":"27161","DOI":"10.1074\/jbc.274.38.27161","volume":"274","author":"H Hanafusa","year":"1999","unstructured":"Hanafusa H, Ninomiya-Tsuji J, Masuyama N, Nishita M, Fujisawa J, Shibuya H et al. (1999). Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression. J Biol Chem 274: 27161\u201327167.","journal-title":"J Biol Chem"},{"key":"BFonc2011429_CR20","doi-asserted-by":"publisher","first-page":"23675","DOI":"10.1074\/jbc.M503323200","volume":"280","author":"J Hang","year":"2005","unstructured":"Hang J, Zemskov EA, Lorand L, Belkin AM . (2005). Identification of a novel recognition sequence for fibronectin within the NH2-terminal beta-sandwich domain of tissue transglutaminase. J Biol Chem 280: 23675\u201323683.","journal-title":"J Biol Chem"},{"key":"BFonc2011429_CR21","doi-asserted-by":"publisher","first-page":"25920","DOI":"10.1074\/jbc.M501150200","volume":"280","author":"BA Hocevar","year":"2005","unstructured":"Hocevar BA, Prunier C, Howe PH . (2005). Disabled-2 (Dab2) mediates transforming growth factor beta (TGFbeta)-stimulated fibronectin synthesis through TGFbeta-activated kinase 1 and activation of the JNK pathway. J Biol Chem 280: 25920\u201325927.","journal-title":"J Biol Chem"},{"key":"BFonc2011429_CR22","first-page":"729","volume":"20","author":"W Hu","year":"2000","unstructured":"Hu W, Wu W, Nash MA, Freedman RS, Kavanagh JJ, Verschraegen CF . (2000). Anomalies of the TGF-beta postreceptor signaling pathway in ovarian cancer cell lines. Anticancer Res 20: 729\u2013733.","journal-title":"Anticancer Res"},{"key":"BFonc2011429_CR23","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1006\/gyno.2001.6376","volume":"83","author":"JA Hurteau","year":"2001","unstructured":"Hurteau JA, Allison BM, Brutkiewicz SA, Goebl MG, Heilman DK, Bigsby RM et al. (2001). Expression and subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in epithelial ovarian cancer. Gynecol Oncol 83: 292\u2013298.","journal-title":"Gynecol Oncol"},{"key":"BFonc2011429_CR24","first-page":"4512","volume":"55","author":"A Kopp","year":"1995","unstructured":"Kopp A, Jonat W, Schmahl M, Knabbe C . (1995). Transforming growth factor beta 2 (TGF-beta 2) levels in plasma of patients with metastatic breast cancer treated with tamoxifen. Cancer Res 55: 4512\u20134515.","journal-title":"Cancer Res"},{"key":"BFonc2011429_CR25","doi-asserted-by":"publisher","first-page":"28937","DOI":"10.1074\/jbc.M909923199","volume":"275","author":"T Lopez-Rovira","year":"2000","unstructured":"Lopez-Rovira T, Chalaux E, Rosa JL, Bartrons R, Ventura F . (2000). Interaction and functional cooperation of NF-kappa B with Smads. Transcriptional regulation of the junB promoter. J Biol Chem 275: 28937\u201328946.","journal-title":"J Biol Chem"},{"key":"BFonc2011429_CR26","first-page":"4227","volume":"58","author":"MA Lynch","year":"1998","unstructured":"Lynch MA, Nakashima R, Song H, DeGroff VL, Wang D, Enomoto T et al. (1998). Mutational analysis of the transforming growth factor beta receptor type II gene in human ovarian carcinoma. Cancer Res 58: 4227\u20134232.","journal-title":"Cancer Res"},{"key":"BFonc2011429_CR27","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY et al. (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704\u2013715.","journal-title":"Cell"},{"key":"BFonc2011429_CR28","doi-asserted-by":"publisher","first-page":"8788","DOI":"10.1158\/0008-5472.CAN-06-1457","volume":"66","author":"AP Mann","year":"2006","unstructured":"Mann AP, Verma A, Sethi G, Manavathi B, Wang H, Fok JY et al. (2006). Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-{kappa}B in cancer cells: delineation of a novel pathway. Cancer Res 66: 8788\u20138795.","journal-title":"Cancer Res"},{"key":"BFonc2011429_CR29","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/S0092-8674(00)81296-9","volume":"85","author":"J Massague","year":"1996","unstructured":"Massague J . (1996). TGFbeta signaling: receptors, transducers, and Mad proteins. Cell 85: 947\u2013950.","journal-title":"Cell"},{"key":"BFonc2011429_CR30","doi-asserted-by":"publisher","first-page":"6289","DOI":"10.1038\/sj.onc.1205785","volume":"21","author":"D Matei","year":"2002","unstructured":"Matei D, Graeber TG, Baldwin RL, Karlan BY, Rao J, Chang DD . (2002). Gene expression in epithelial ovarian carcinoma. Oncogene 21: 6289\u20136298.","journal-title":"Oncogene"},{"key":"BFonc2011429_CR31","doi-asserted-by":"publisher","first-page":"8068","DOI":"10.1158\/1078-0432.CCR-04-1107","volume":"10","author":"K Mehta","year":"2004","unstructured":"Mehta K, Fok J, Miller FR, Koul D, Sahin AA . (2004). Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer. Clin Cancer Res 10: 8068\u20138076.","journal-title":"Clin Cancer Res"},{"key":"BFonc2011429_CR32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1158\/0008-5472.CAN-10-2651","volume":"71","author":"KS Mohammad","year":"2011","unstructured":"Mohammad KS, Javelaud D, Fournier PG, Niewolna M, McKenna CR, Peng XH et al. (2011). TGF-beta-RI kinase inhibitor SD-208 reduces the development and progression of melanoma bone metastases. Cancer Res 71: 175\u2013184.","journal-title":"Cancer Res"},{"key":"BFonc2011429_CR33","doi-asserted-by":"publisher","first-page":"9543","DOI":"10.1158\/0008-5472.CAN-06-0479","volume":"66","author":"G Moreno-Bueno","year":"2006","unstructured":"Moreno-Bueno G, Cubillo E, Sarrio D, Peinado H, Rodriguez-Pinilla SM, Villa S et al. (2006). Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition. Cancer Res 66: 9543\u20139556.","journal-title":"Cancer Res"},{"key":"BFonc2011429_CR34","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/329341a0","volume":"329","author":"A Nagafuchi","year":"1987","unstructured":"Nagafuchi A, Shirayoshi Y, Okazaki K, Yasuda K, Takeichi M . (1987). Transformation of cell adhesion properties by exogenously introduced E-cadherin cDNA. Nature 329: 341\u2013343.","journal-title":"Nature"},{"key":"BFonc2011429_CR35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0303-7207(01)00584-6","volume":"182","author":"E Nilsson","year":"2001","unstructured":"Nilsson E, Doraiswamy V, Parrott JA, Skinner MK . (2001). Expression and action of transforming growth factor beta (TGFbeta1, TGFbeta2, TGFbeta3) in normal bovine ovarian surface epithelium and implications for human ovarian cancer. Mol Cell Endocrinol 182: 145\u2013155.","journal-title":"Mol Cell Endocrinol"},{"key":"BFonc2011429_CR36","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/32433","volume":"392","author":"AK Perl","year":"1998","unstructured":"Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G . (1998). A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392: 190\u2013193.","journal-title":"Nature"},{"key":"BFonc2011429_CR37","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/0003-9861(68)90557-2","volume":"126","author":"JH Pincus","year":"1968","unstructured":"Pincus JH, Waelsch H . (1968). The specificity of transglutaminase. II. Structural requirements of the amine substrate. Arch Biochem Biophys 126: 44\u201352.","journal-title":"Arch Biochem Biophys"},{"key":"BFonc2011429_CR38","doi-asserted-by":"publisher","first-page":"17562","DOI":"10.1074\/jbc.M500646200","volume":"280","author":"B Qiao","year":"2005","unstructured":"Qiao B, Padilla SR, Benya PD . (2005). Transforming growth factor (TGF)-beta-activated kinase 1 mimics and mediates TGF-beta-induced stimulation of type II collagen synthesis in chondrocytes independent of Col2a1 transcription and Smad3 signaling. J Biol Chem 280: 17562\u201317571.","journal-title":"J Biol Chem"},{"key":"BFonc2011429_CR39","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1006\/gyno.2000.6042","volume":"80","author":"GC Rodriguez","year":"2001","unstructured":"Rodriguez GC, Haisley C, Hurteau J, Moser TL, Whitaker R, Bast Jr RC et al. (2001). Regulation of invasion of epithelial ovarian cancer by transforming growth factor-beta. Gynecol Oncol 80: 245\u2013253.","journal-title":"Gynecol Oncol"},{"key":"BFonc2011429_CR40","doi-asserted-by":"publisher","first-page":"7194","DOI":"10.1158\/0008-5472.CAN-07-0307","volume":"67","author":"M Satpathy","year":"2007","unstructured":"Satpathy M, Cao L, Pincheira R, Emerson R, Bigsby R, Nakshatri H et al. (2007). Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase. Cancer Res 67: 7194\u20137202.","journal-title":"Cancer Res"},{"key":"BFonc2011429_CR41","doi-asserted-by":"publisher","first-page":"15390","DOI":"10.1074\/jbc.M808331200","volume":"284","author":"M Satpathy","year":"2009","unstructured":"Satpathy M, Shao M, Emerson R, Donner DB, Matei D . (2009). Tissue transglutaminase regulates matrix metalloproteinase-2 in ovarian cancer by modulating cAMP-response element-binding protein activity. J Biol Chem 284: 15390\u201315399.","journal-title":"J Biol Chem"},{"key":"BFonc2011429_CR42","doi-asserted-by":"publisher","first-page":"9192","DOI":"10.1158\/0008-5472.CAN-09-1257","volume":"69","author":"M Shao","year":"2009","unstructured":"Shao M, Cao L, Shen C, Satpathy M, Chelladurai B, Bigsby RM et al. (2009). Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminase. Cancer Res 69: 9192\u20139201.","journal-title":"Cancer Res"},{"key":"BFonc2011429_CR43","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1002\/ijc.24188","volume":"124","author":"KL Sodek","year":"2009","unstructured":"Sodek KL, Ringuette MJ, Brown TJ . (2009). Compact spheroid formation by ovarian cancer cells is associated with contractile behavior and an invasive phenotype. Int J Cancer 124: 2060\u20132070.","journal-title":"Int J Cancer"},{"key":"BFonc2011429_CR44","doi-asserted-by":"publisher","first-page":"11154","DOI":"10.1073\/pnas.0603672103","volume":"103","author":"PP Szotek","year":"2006","unstructured":"Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R et al. (2006). Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian inhibiting substance responsiveness. Proc Natl Acad Sci USA 103: 11154\u201311159.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2011429_CR45","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrc822","volume":"2","author":"JP Thiery","year":"2002","unstructured":"Thiery JP . (2002). Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442\u2013454.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2011429_CR46","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1083\/jcb.200512110","volume":"174","author":"S Thuault","year":"2006","unstructured":"Thuault S, Valcourt U, Petersen M, Manfioletti G, Heldin CH, Moustakas A . (2006). Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition. J Cell Biol 174: 175\u2013183.","journal-title":"J Cell Biol"},{"key":"BFonc2011429_CR47","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/sj.onc.1205026","volume":"21","author":"SW Tobin","year":"2002","unstructured":"Tobin SW, Douville K, Benbow U, Brinckerhoff CE, Memoli VA, Arrick BA . (2002). Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects. Oncogene 21: 108\u2013118.","journal-title":"Oncogene"},{"key":"BFonc2011429_CR48","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/ncb1905","volume":"11","author":"T Vincent","year":"2009","unstructured":"Vincent T, Neve EP, Johnson JR, Kukalev A, Rojo F, Albanell J et al. (2009). A SNAIL1-SMAD3\/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition. Nat Cell Biol 11: 943\u2013950.","journal-title":"Nat Cell Biol"},{"key":"BFonc2011429_CR49","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/jcb.20160","volume":"93","author":"K Wakahara","year":"2004","unstructured":"Wakahara K, Kobayashi H, Yagyu T, Matsuzaki H, Kondo T, Kurita N et al. (2004). Transforming growth factor-beta1-dependent activation of Smad2\/3 and up-regulation of PAI-1 expression is negatively regulated by Src in SKOV-3 human ovarian cancer cells. J Cell Biochem 93: 437\u2013453.","journal-title":"J Cell Biochem"},{"key":"BFonc2011429_CR50","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1006\/gyno.1999.5535","volume":"75","author":"SD Yamada","year":"1999","unstructured":"Yamada SD, Baldwin RL, Karlan BY . (1999). Ovarian carcinoma cell cultures are resistant to TGF-beta1-mediated growth inhibition despite expression of functional receptors. Gynecol Oncol 75: 72\u201377.","journal-title":"Gynecol Oncol"},{"key":"BFonc2011429_CR51","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1126\/science.270.5244.2008","volume":"270","author":"K Yamaguchi","year":"1995","unstructured":"Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N et al. (1995). Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 270: 2008\u20132011.","journal-title":"Science"},{"key":"BFonc2011429_CR52","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature02545","volume":"429","author":"S Yamashita","year":"2004","unstructured":"Yamashita S, Miyagi C, Fukada T, Kagara N, Che YS, Hirano T . (2004). Zinc transporter LIVI controls epithelial-mesenchymal transition in zebrafish gastrula organizer. Nature 429: 298\u2013302.","journal-title":"Nature"},{"key":"BFonc2011429_CR53","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S1097-2765(00)80061-1","volume":"1","author":"L Zawel","year":"1998","unstructured":"Zawel L, Dai JL, Buckhaults P, Zhou S, Kinzler KW, Vogelstein B et al. (1998). Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell 1: 611\u2013617.","journal-title":"Mol Cell"},{"key":"BFonc2011429_CR54","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1074\/jbc.273.4.2288","volume":"273","author":"J Zhang","year":"1998","unstructured":"Zhang J, Lesort M, Guttmann RP, Johnson GV . (1998). Modulation of the in situ activity of tissue transglutaminase by calcium and GTP. J Biol Chem 273: 2288\u20132295.","journal-title":"J Biol Chem"},{"key":"BFonc2011429_CR55","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.1158\/0008-5472.CAN-08-0364","volume":"68","author":"S Zhang","year":"2008","unstructured":"Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM et al. (2008). Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 68: 4311\u20134320.","journal-title":"Cancer Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2011429.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2011429","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2011429.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T18:32:20Z","timestamp":1647887540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2011429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,3]]},"references-count":55,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2012,5,17]]}},"alternative-id":["BFonc2011429"],"URL":"https:\/\/doi.org\/10.1038\/onc.2011.429","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,3]]},"assertion":[{"value":"3 February 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}